Protein hydrolysate with antidiabetic effect

Details for Australian Patent Application No. 2005302921 (hide)

Owner MG Pharma Inc.

Inventors Naruse, Toshihiko; Kagawa, Kyoichi; Fukuhama, Chizuko

Agent Pizzeys

Pub. Number AU-B-2005302921

PCT Pub. Number WO2006/052031

Priority 60/627,843 15.11.04 US

Filing date 15 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 23 September 2010

International Classifications

C07K 5/103 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A23L 1/305 (2006.01) Foods or foodstuffs - Amino acids, peptides or proteins

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/052031 Priority application(s): WO2006/052031

23 September 2010 Application Accepted

  Published as AU-B-2005302921

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005302930-Nozzle structure of bidet with swirling water current

2005302908-Aqueous ophthalmic suspension of crystalline rebamipide